series-a
Stage
2
Investors
About
Newcells Biotech develops advanced in vitro tissue models that mimic human physiology to improve drug discovery and clinical translation, offering services such as disease modeling, toxicology safety studies, and drug interaction studies for pharmaceutical and biotechnology companies.
Explore Newcells Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.